Sai Parenteral IPO Sees Muted Opening With Just 4% Subscription on Day One
Sai Parenteral's IPO has drawn lukewarm investor response on its first day, with subscription levels at merely 4% and zero grey market premium, signaling cautious sentiment despite the company's growth prospects.